News
StockStory.org on MSN17h
CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost
Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...
Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.
Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and PBMI Innovator Award winner, is calling for a PBM industry focus on making pharmacy experiences more seamless while continuing to ...
O'Reilly Automotive Inc. is suing the three major pharmacy benefit managers in the U.S., as well as the three major insulin manufacturers.
The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...
CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found it violated state code. The $1.4 million fine is based on 2,871 violations, ...
While competitors continue to struggle with healthcare costs, Aetna and CVS are celebrating an 8.4% increase in ...
CVS Health said it plans to allocate $20 billion over the next decade to streamline the US health system. The initiative aims ...
CVS Health reports Q2 earnings decline due to litigation charges but boost adjusted EPS guidance, highlighting transformation ...
Aetna saw its medical benefits ratio increase months after CVS announced it would exit the ACA individual market due to struggling performance.
But overall, we would not be surprised to see CVS continue in that pattern of leverage-increasing acquisitions, deleveraging by constraining other capital-allocation activities, hitting its leverage ...
CVS Health reported second quarter total revenues increased to $98.9 billion, up 8.4% compared to the prior year period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results